Trademark: BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Track updates on BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV
Mark Identification
BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV
Click here to search for trademarks similar to BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV
Proof of use for BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV
We do not have any records of a proof of use for BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV at this moment.
Click here to add a proof of use for BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV
Possible trademark infringements of BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV
Basic Information
- Serial Number
- 97715586
- Filing Date
- 13 Dec 2022
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV on the blockchain with WikiTrademarks.io.
- First use anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
Ownership history of this trademark/brand
1. TG THERAPEUTICS, INC. New York NY
2. TG THERAPEUTICS, INC. New York NY
Correspondent
- Maury M. Tepper, III
- TEPPER & EYSTER, PLLC
- 3724 BENSON DR
- RALEIGH,NC 27609
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io
Track updates on BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV